drugset / Trial / NCT06738745
Study of HRS-2189 Combined HRS-5041 in Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
Our study is aimed to evaluate the efficacy and safety of HRS-2189 combined with HRS-5041 in metastatic prostate cancer.
Timeline
- Start
- 2024-12-31
- Primary completion
- 2027-01-31
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-2189 | Unknown | — | — |
| Subject | HRS-5041 | Other / unclassified | — | — |